New research suggests that electrical spinal cord stimulation could improve muscle function for patients who have spinal ...

Alterity Therapeutics Ltd. reported positive top-line phase II results for lead candidate ATH-434 for treating multiple ...

Alterity plans to seek US FDA fast-track approval after posting positive phase II results for multiple system atrophy ...

MSA is a Parkinsonian disorder characterized ... chemical compounds to treat the underlying pathology of neurological diseases. The Company is based in Melbourne, Australia, and San Francisco ...

The University of Chicago and Queen's Health System will evaluate gaps in healthcare access, disease progression and survival in racial and ethnic minority populations with PSP, CBD or MSA.